Asthma-related microbes
Asthma is a chronic inflammatory disease of the airways characterized by variable and recurring symptoms, airflow obstruction, and bronchospasm. Recent studies have suggested that certain microbes may play a role in the development and exacerbation of asthma. This article explores the relationship between asthma and specific microbes, including Chlamydia pneumoniae, Mycoplasma pneumoniae, and Human rhinovirus.
Chlamydia pneumoniae[edit]
Chlamydia pneumoniae is a species of bacteria that can cause respiratory tract infections. It has been implicated in the exacerbation of asthma symptoms. The bacterium is known to infect the epithelial cells of the respiratory tract, leading to inflammation and potentially worsening asthma control. Studies have shown that patients with asthma may have a higher prevalence of C. pneumoniae infection compared to non-asthmatic individuals.
Mycoplasma pneumoniae[edit]
Mycoplasma pneumoniae is a type of bacteria that lacks a cell wall and is known to cause atypical pneumonia. It has also been associated with asthma exacerbations. M. pneumoniae can trigger immune responses that lead to increased airway inflammation and hyperreactivity, which are hallmarks of asthma. The presence of M. pneumoniae in the respiratory tract of asthmatic patients may contribute to the severity and frequency of asthma attacks.
Human rhinovirus[edit]
Human rhinovirus is a common viral infectious agent that causes the common cold. It is one of the most frequent triggers of asthma exacerbations, especially in children. The virus infects the upper respiratory tract and can lead to increased airway inflammation and obstruction in asthmatic individuals. Rhinovirus infections are associated with increased morbidity in asthma patients, and managing these infections is crucial for controlling asthma symptoms.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
